Yonsei University

Immunomet Therapeutics Inc.

Republic of Korea (minister of Food and Drug Safety)

Sang Jun Ha

Beom Seok Kim

Hye Ryun Kim

Ji Min Son

Dae Hee Hwang

Bo Ryeong Lee

Hyo Sup Shim

Jungsik Song

Jung Yeon Yi

Provided in the present disclosure are a method for providing information on a therapeutic reaction of cancer immunotherapy and a kit using same for providing information, the method comprising the steps of: measuring respective expression levels of PD-L1 and PVR in a biological sample isolated from a subject; and evaluating the therapeutic reaction of cancer immunotherapy for the subject on the basis of the measured expression levels of PD-L1 and PVR.

Methods for treating non-small lung cancer and for preparing a sample

Provided are a pharmaceutical composition for preventing or treating inflammatory disease, autoimmune disease, graft rejection responses, or combinations thereof, the pharmaceutical composition including a compound represented by Formula 1, or a stereoisomer, derivative, solvate, or pharmaceutically acceptable salt thereof, and a method using the pharmaceutical composition. The pharmaceutical composition and the method can be used to effectively prevent or treat inflammatory disease, autoimmune disease, graft rejection responses, or combinations thereof.

Pharmaceutical compositions for preventing or treating inflammatory disease, autoimmune disease, or combination thereof, and method for using same

Growing community of inventors

Seoul, South Korea

Sang Jun Ha